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Purpose: This retrospective review describes the use and clinical outcome of cold perfusion protection during branch renal
artery (RA) repair in 77 consecutive patients.
Methods: From July 1987 through November 2006, 874 patients had open operative RA repair to 1312 kidneys.
Seventy-seven patients (62 women, 15 men; mean age, 44  17 years) had branch RA reconstruction using ex vivo or in
situ cold perfusion protection for 78 kidneys. Demographic data and surgical technique were examined. Blood pressure
response and renal function were estimated. Patency of repair was determined by angiography and renal duplex
ultrasound (RDUS) imaging. Primary RA patency was estimated by life-table methods.
Results: Seventy-eight RAs were repaired using ex vivo (49 kidneys) or in situ (29 kidneys) cold perfusion protection.
Bilateral RA repair was performed in eight patients, with 13 repairs to solitary kidneys. RA disease included aneurysm
(RAA) in 50, fibromuscular dysplasia (FMD) in 37, atherosclerosis in 5, and arteritis in 2; 16 patients had both FMD and
RAA. Hypertension was present in 93.5% (mean blood pressure, 184 35/107 19 mmHg; mean of 1.9 1.1 drugs).
RA repair included bypass using saphenous vein in 69, hypogastric artery in 3, polytetrafluoroethylene (PTFE) in 2,
composite vein/PTFE in 2, cephalic vein in 1, or aneurysmorrhaphy in 1. The eight bilateral RA repairs were staged. One
patient required bilateral cold perfusion protection. One planned nephrectomy was performed at the time of contralateral
ex vivo reconstruction. No primary nephrectomies were required for intended reconstruction. Each RA reconstruction
required branch dissection and reconstruction (mean of 2.8 1.6 branches were repaired). Mean cold ischemia time was
125  40 minutes. Each kidney was reconstructed in an orthotopic fashion. Five early failures of repair required three
nephrectomies and one operative revision. Based on postoperative angiography or RDUS, or both, primary patency of RA
repair at 12 months was 85%  5%; assisted primary patency was 93%  4%. Among patients with preoperative
hypertension, 15% were cured, 65% were improved, and 20% were considered failed. Early renal function was improved
in 35%, unchanged in 48%, and worse in 17%. Four patients had perioperative acute tubular necrosis. No patient
progressed to dialysis-dependence.
Conclusion: Both ex vivo and in situ cold perfusion protection extend the safe renal ischemia time for complex branch RA
repair and avoid the need for nephrectomy. (J Vasc Surg 2007;46:405-12.)Percutaneous transluminal renal artery angioplasty
(PTRA), with or without endoluminal stents, has been
adopted as the preferred treatment of renovascular disease
in many centers despite the absence of supporting class I
evidence. Technical success and periprocedural morbidity
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doi:10.1016/j.jvs.2007.04.036appear optimal when PTRA is applied to stenotic lesions
secondary to atherosclerosis or medial fibroplasia of the
main renal artery.1-6 Less favorable technical and long-term
results have been observed when catheter-based interven-
tion has been applied to stenotic or aneurysmal lesions
involving renal artery branches.7-9 Consequently, a signifi-
cant proportion of patients now chosen for operative repair
often require branch renal artery exposure and reconstruc-
tion. These procedures may require complex surgical re-
construction culminating in prolonged warm renal isch-
emia. Available data suggest that when 30 to 40 minutes
of warm ischemia are required for revascularization, mea-
sures to protect renal function should be instituted.10-13
Although several pharmacologic therapies have been
promoted to provide renal preservation, no therapy to date
has equaled hypothermia for protection when renal isch-
emia approaches 2 hours.10,14-17 Both surface cooling and
various methods of perfusion hypothermia have been
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defined.10,13,15,18-23 In light of these uncertainties, this
retrospective report describes our institution’s experience
with complex renal artery repair requiring hypothermic
preservation. The intent of the review is to describe (1) the
renal artery lesions managed by these techniques, (2) the
methods and techniques of renal protection, (3) the hyper-
tension and renal function response to operative manage-
ment, and (4) the patency of renal artery repair.
METHODS
Patient population. Patients who underwent renal
artery reconstruction were identified from an Institutional
Review Board-approved vascular registry. From July 1987
through November 2006, 874 patients had open operative
renal artery repair to 1312 kidneys at Wake Forest Univer-
sity Baptist Medical Center. Those patients who had recon-
struction using cold perfusion protection were selected.
Branch renal artery reconstruction was done in 77
consecutive patients (62 women, 15 men; mean age, 44 
17 years) using either ex vivo or in situ cold perfusion
protection for 78 kidneys. Patient demographics and pre-
operative clinical characteristics are depicted in Table I. The
hospital records, imaging studies, and clinic records for all
patients were reviewed. Demographic data, surgical tech-
nique, perioperative morbidity, and mortality were exam-
ined. Postoperative patency of repair was determined by
angiography or renal duplex ultrasound (RDUS) imaging,
or both.
Measured clinical outcomes included blood pressure,
number of antihypertensive medications, and serum creat-
inine (SCr). Analysis was performed using data from the
preoperative assessment, discharge assessment, and the lat-
est postoperative follow-up. Blood pressure response was
estimated as previously described.24 Preoperative and post-
operative SCr concentrations were measured, and estimated
glomerular filtration rate (EGFR;mL/[min · 1.73m2]) was
Table I. Patient characteristics
Patients (n  77) N or mean  SD
Age (year) 44  17
Gender
Male 15
Female 62
Race
White 63
African American 11
Other 3
Hypertension
Pre-op SBP (mm Hg) 184  35
Pre-op DBP (mm Hg) 107  19
Pre-op BP meds (n) 1.9  1.1
Renal function
Pre-op serum creatinine 1.03  0.43
Pre-op EGFR (ml/[min · 1.73 m2]) 79  30
SD, Standard deviation; SBP, systolic blood pressure; DBP, diastolic blood
pressure; EGFR, estimated glomerular filtration rate.calculated by a validated prediction equation.24 Early renalfunction was considered improved, unchanged, or wors-
ened using a20% change in SCr level at discharge. Acute
tubular necrosis (ATN) was defined as a 20% increase in
the SCr level during hospitalization 1.3 in women and
1.5 in men. Late renal function response was considered
improved, unchanged or worsened using a20% change in
EGFR at last follow-up.
Surgical technique. Isolated branch renal artery re-
pair is performed through an extended subcostal incision.
The patient is positioned with a roll beneath the ipsilateral
flank and the ipsilateral arm is padded and tucked. A kidney
rest is elevated and the patient is flexed to increase the
distance between the costal margin and pelvic crest.
A right or left visceral mobilization is performed. On
the right, adhesions between the anterior and posterior
liver are divided first, retracting the liver superiorly. A
continuous incision in the posterior peritoneum is made to
mobilize the duodenum and the hepatic flexure of the
colon, entering a retroperitoneal plane anterior to Gerota’s
fascia to expose the right renal vein and vena cava. The
duodenum and colon are swept medially and inferiorly to
the left of the aorta. On the left, the descending colon and
splenic flexure are mobilized at the lateral peritoneal reflec-
tion, developing a plane anterior to Gerota’s fascia and the
left renal vein. In most cases, the spleen and pancreas can be
left in position, mobilizing the inferior border of the pan-
creas and retracting this organ superiorly.
In branch renal artery exposure for either kidney, early
identification and mobilization of the renal vein are key.
The renal vein is mobilized from the renal hilum to caval
origin. On the left, the adrenal, gonadal, and lumbar vein
branches are ligated. When the renal artery pathology in-
volves the distal renal artery and hilar vessels, the proximal
renal artery is exposed first. When reconstruction is per-
formed for failed percutaneous angioplasty or failed surgi-
cal repair associated with significant periarterial fibrosis,
dissection is begun distally at the renal hilum through
undisturbed tissue planes. During renal artery dissection
small (6.25 to 12.5 g) doses of intravenous mannitol are
administered intermittently and then repeated during peri-
ods of initial ischemia and reperfusion.Mannitol is given up
to a maximum cumulative dose of 1 g/kg of patient body
weight.
Cold perfusion protection is used when 30 to
40 minutes of warm renal ischemia is anticipated to com-
plete the renal artery repair. Cold perfusion preservation is
initiated after complete mobilization of the kidney from
Gerota’s space and dissection of the hilar structures. Mobi-
lization begins at the superior pole of the kidney after a
cruciate incision is made in Gerota’s fascia. At the inferior
pole of the kidney, the ureter is identified and mobilized to
the level of the pelvic brim with abundant periureteric
fibroareolar tissue. The ureter is left intact, but periureteric
collaterals are controlled throughout the period of ischemia
with doubly passed elastic loops. In the final portion of
exposure, the posterior renal hilum is cleared of all sur-
rounding tissues, thereby eliminating contamination of the
systemic circulation with cold perfusate.
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heparinized. The renal artery is ligated and divided. The
renal vein is controlled at its juncture with the vena cava.
When exposure is adequate, the in situ technique leaves the
renal vein intact and a venotomy is made before cold
perfusion of the kidney (Fig 1, A ). When exposure and
reconstruction require elevation of the kidney from
Gerota’s space, the ex vivo technique divides the renal
vein with a cuff of vena cava (Fig 1, B ). In either case, the
kidney is placed on a plastic barrier drape, immersed in ice
slush, and flushed with a commercially available renal pres-
ervation solution with intracellular composition that has
been chilled to 4°C. The kidney should appear asanguine-
ous, with clear effluent from the renal vein, which typically
requires 300 to 500 mL of perfusate. The remainder of the
hilar dissection is then completed sharply. Before final
division of the renal artery branches, the kidney is once
again infused with chilled perfusate and branch renal artery
Fig 1. Branch renal artery repair with cold perfusion
mobilization and reconstruction is performed without tr
vena cava containing the renal vein origin is excised to aid
branches and creation of the distal anastomosis. A pro
reconstruction.repair performed.In most instances, branch repair involves combining
(or syndactylizing) renal artery branches, especially when
multiple segmental renal arteries are reconstructed
(Fig 1, C ). The segmental vessels are tailored and su-
tured together to create one or two common orifices
bearing the circulation to the kidney. The distal anasto-
mosis between the syndactylized patch and the bypass
conduit is then performed.
Once the distal arterial reconstruction is completed, the
renal vein is repaired. For ex vivo repair, the kidney is placed
in an orthotopic position and an anastomosis from the renal
vein to the vena cava is created. For the in situ technique,
the venotomy is simply closed.
In the final stage of reconstruction, the proximal bypass
graft is anastomosed to the aorta. On the right, the renal
artery conduit is routed posterior to the vena cava except in
those cases when branch renal reconstruction is required
for failed angioplasty or failed surgical repair. In these cases,
rvation. A, In situ repair using cold perfusion. Renal
ting the renal vein. B, Ex vivo repair, where an ellipse of
posure.C, Syndactilization, or combining, of segmental
branch is sewn to the graft separately. D, Completedprese
ansec
in ex
ximalthere is often a retrocaval cicatrix that makes dissection in
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mobilized, and one or two pairs of lumbar veins are ligated
and divided. The infrarenal aorta is mobilized, preserving
all lumbar arteries, and then controlled with clamps. An an-
terolateral ellipse of aortic wall is removed using several
applications of an aortic punch. The renal conduit is then
spatulated and sewn in an end-to-side fashion to the aorta
(Fig 1, D).
For the entirety of the ischemic period, the kidney is
maintained in ice slush. Before reperfusion, the kidney is
removed from slush, the renal vessels are released simulta-
neously, and the ureter loop is released. Ureteric peristalsis
resumes within 15 minutes in most cases.
Regardless of themethod of reconstruction, each repair
is evaluated with intraoperative RDUS imaging. B-scan
images are obtained from all areas of operative dissection
and vascular reconstruction. A B-scan defect is imaged in
both longitudinal and transverse projection, and Doppler
samples are obtained proximal and distal to an imaged
defect to determine their contribution to flow disturbance.
Color-flow is taken from the renal parenchyma in the
upper, middle, and inferior kidney, and Doppler parenchy-
mal signals are obtained. The criteria for major B-scan
defects requiring immediate revision are (1) a focal peak
systolic velocity1.8 m/s with a distal turbulent waveform
and (2) no Doppler-shifted signal from the renal artery
(consistent with occlusion).
Statistical methods. Data were examined for all pa-
tients who underwent branch renal artery reconstruction
using cold perfusion protection. Descriptive statistics were
computed, including means  standard deviations of con-
tinuous variables and frequencies and percents of categoric
variables. Changes in blood pressure and renal function
(SCr or EGFR) were assessed using paired t tests. Censored
outcomes (primary renal artery patency and patient sur-
vival) were estimated by life-table methods. Graphic depic-
tion of patency was constructed using product-limit esti-
mates (Fig 2).
RESULTS
Operative management. Cold perfusion was used to
repair 78 renal arteries by ex vivo (49 kidneys) or in situ (29
kidneys) techniques (Table II). Of the 29 patients with
bilateral disease or disease to a solitary kidney, bilateral
renal artery repair was performed in eight patients, with 13
repairs to solitary kidneys. Bilateral renal artery repairs were
performed in a staged fashion (mean interval, 8.6 months).
One patient had bilateral cold perfusion renal artery recon-
struction and seven had unilateral reconstruction using
cold perfusion protection and contralateral warm in situ
reconstruction. Renal artery disease included renal artery
aneurysm (RAA) in 50 patients, fibromuscular dysplasia
(FMD) in 37, atherosclerosis in 5, and arteritis in 2; 16
patients had both FMD and RAA. Renal artery reconstruc-
tion was performed in six patients who had failed PTRA (4
ex vivo, 2 in situ). All six patients had FMD and significant
hypertension.Of 78 renal artery repairs, saphenous vein was used in
69, hypogastric artery in 3, composite vein/polytetrafluo-
roethylene (PTFE) in 2, PTFE in 2, cephalic vein in 1, and
aneurysmorrhaphy in 1. One planned nephrectomy was
performed at the time of contralateral ex vivo renal artery
reconstruction for unreconstructable renal artery disease.
No unplanned nephrectomies were required for intended
reconstruction. Each renal artery reconstruction required
branch dissection and reconstruction (mean 2.8  1.6
Fig 2. Product-limit estimates of primary patency (blue) and
primary-assisted patency (red) in 68 arteries. The standard error of
the estimate never exceeds 10%.
Table II. Characteristics of renal artery repairs
Characteristic RAs
Unilateral repair 57
Right 40
Left 17
Bilateral repair 8
Bilateral cold perfusion 1
Unilateral cold perfusion 7
Solitary kidneys 13
Associated conditions
Fibromuscular dysplasia 37
Atherosclerosis 5
RAA 50
Arteritis 2
Ex vivo 49
In situ 29
Branch number* 2.8  1.6
Cold perfusion after:
Failed PTRA 6
Failed open RA repair 1
RA, Renal artery; RAA, renal artery aneurysm; PTRA, percutaneous trans-
luminal renal artery angioplasty.
*Branch number expressed as mean  standard deviation.branches were repaired). Mean operative time was 7.75 
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cold ischemia time was 125 40minutes. Each kidney was
reconstructed in an orthotopic fashion.
Intraoperative duplex imaging (48 kidneys) and early
postoperative angiography/RDUS imaging (18 patients)
defined significant technical defects in 12 patients (18.2%).
Seven renal arterial reconstructions with major B-scan de-
fects noted on intraoperative RDUS imaging were revised
immediately, with completion duplex imaging to insure a
satisfactory result. Postoperative angiography or RDUS
imaging, or both, demonstrated five occlusions.
Morbidity and mortality. Perioperative complica-
tions that extended the hospital stay occurred in 5.2% of
patients. These included ileus in 1 patient, wound infection
in 2, sacral decubitus ulcer in 1, and respiratory failure,
pneumonia, and need for temporary dialysis in 1 patient.
The latter patient underwent renal artery bypass to a soli-
tary kidney, which thrombosed in the immediate perioper-
ative period requiring emergent surgical revision. Renal
failure developed despite a patent graft, and he required 1
week of hemodialysis. After 1 month of hospitalization, the
patient was discharged home off dialysis, with a stable
EGFR. No additional hemodialysis was required during 19
months of follow-up.
Five early repair failures required three nephrectomies
(Table III). One perioperative graft occlusion to a solitary
kidney was reoperated on with successful kidney salvage (as
noted previously). The remaining patients were asymptom-
atic, and their graft occlusions were identified on routine
postoperative angiography or RDUS imaging, or both.
One perioperative death occurred (1.3%) in a patient
Table III. Outcomes
Outcome N (%)
Hypertension response*
Cured 11 (15)
Improved 47 (65)
Failed 14 (20)
Renal function
Early
Improved 21 (35)
Unchanged 29 (48)
Worsened 10 (17)
Late
Improved 13 (37)
Unchanged 16 (46)
Worsened 6 (17)
Patency†
Primary 85  5
Primary-assisted 93  4
Occlusions 5  7.4
Anatomic follow-up‡ 34  7
Mortality
In-hospital 1 (1.3  1.3)
Long-term mortality 3 (3.9  2.2)
*Hypertension response, renal function response, occlusions, and mortality
expressed as number of patients (percentages).
†Patency at 12 months, expressed as percentages with standard error.
‡Expressed as months  standard deviation.who had advanced cirrhosis and a large, symptomatic RAA.Postoperative hemorrhage led to multisystem organ dys-
function, acute respiratory distress syndrome, and death.
No late graft occlusions occurred, and no patients
progressed to dialysis-dependence. Long-term follow-up
for vital status was a mean 7.3 years (range, 0 to 17 years;
median, 7.7 years). Two late deaths occurred, one at 8.4
years and one at 14.2 years. The product-limit estimate of
survival was 96% at 10 years.
Blood pressure response. Preoperative hypertension
was present in 93.5% of patients (mean blood pressure,
184  35/107  19 mm Hg; mean number medications,
1.9 1.1). Among the 72 hypertensive patients, 15% were
cured, 65% were improved, and 20% were considered failed
after renal artery repair (Table III).24 Considered collec-
tively, hypertensive patients had decreased systolic and
diastolic blood pressures (141 21/83 12 mmHg; P
.0001) as well as decreased medication requirements for
adequate blood pressure control (medications, 1.5  1.5;
P .0001). Of the six patients who underwent repair after
failed PTRA, hypertension was cured in four and improved
in two. Bilateral disease or disease to a solitary kidney was
noted in 29 patients, of which eight had bilateral repair,
including one with bilateral cold perfusion. Eight patients
with bilateral disease had only unilateral repair when blood
pressure was cured or improved after the first operation.
Early renal function. Early renal function was im-
proved in 35% of patients, preserved in 48%, and worse in
17% after renal artery repair (mean preoperative SCr, 1.0
0.36; mean discharge SCr, 0.91  0.45; Table III). Four
patients (7.1%) had ATN in the postoperative period.Mean
preoperative SCr in these patients was 1.83  0.72 com-
pared with a postoperative SCr of 2.23 0.67. One of the
four patients with ATN required temporary hemodialysis
(as described previously). Two of the patients with ATN
had early graft occlusions, one of which was noted on
routine postoperative angiography.
Renal function response. Late renal function re-
sponse was available for 35 of 77 patients (Table III). The
average time to follow-up EGFR was 12 months (median,
3.4 months; range, 0.70 to 80 months). The EGFR was
improved in 37%, unchanged in 46%, and worse in 17%
(mean preoperative EGFR, 76.2  31.7; mean follow-up
EGFR, 83.0  41.9; mean change EGFR, 6.8  30.5). In
the eight patients with preoperative renal insufficiency and
follow-up, renal function was improved in four, unchanged
in three, and worse in one (mean preoperative EGFR,
41.3  14.7; mean follow-up EGFR, 55.1  28.2). Three
of the four patients with perioperative ATN had follow-up
SCr for analysis. Of those, two had unchanged EGFR on
last follow-up and one had a slow decline in EGFR over 3
years despite a patent graft (preoperative EGFR, 53.8;
follow-up EGFR, 26.0). No patients have required perma-
nent dialysis in a mean follow-up of 34 months.
Estimated patency of repair. Of the 77 patients, 68
had anatomic follow-up (mean, 34  47 months; range, 1
week to 198 months). Estimated primary patency of renal
artery repair using angiography or RDUS imaging, or both,
was 85%  5% at 12 months (Table III). Graft stenoses
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duplex imaging and two on follow-up angiography per-
formed for recurrent hypertension. Of these, 1 refused
reintervention, 2 underwent successful operative revision at
the time of a contralateral renal artery repair, 1 had success-
ful angioplasty and endoluminal stenting, and 1 patient had
operative revision to a solitary kidney. The product-limit
estimate of primary assisted patency was 93%  4% at 12
months. (Fig 2, Appendix, online only.)
DISCUSSION
Basic data pertaining to the tolerance of the human
kidney to warm renal ischemia are incomplete. Renal toler-
ance to ischemia is in part related to the duration of
ischemia, to the adequacy of collateral circulation, and to
the method of vascular control. In this latter regard, unpro-
tected warm renal ischemia is best tolerated when only the
renal artery is controlled.10 Control of both renal artery and
vein is associated with greater dysfunction than isolated
arterial control, as is intermittent control with repeated
renal perfusion.10,21,25,26
Early canine experiments demonstrated graded levels
of decreased renal function associated with increased peri-
ods of unprotected warm ischemia.10 Although the time
associated with irreparable renal damage cannot be pre-
cisely defined clinically, 20 minutes of warm ischemia in a
canine model was associated with recovery of renal function
in minutes to hours, 30 minutes of unprotected ischemia
required 3 to 9 days for recovery, and 2 hours ischemia was
associated with permanent loss of 30% to 50% of renal
function. Based on these data and similar observations in
clinical practice, we use methods of renal protection when
more than 30 to 40 minutes of warm ischemia would be
anticipated for renal artery repair.
Several pharmacologic strategies for renal protection
during warm ischemia have been proposed.17,27,28 In gen-
eral, these strategies have sought to reduce intrarenal vaso-
constriction, stabilize cellular and subcellular membranes,
or provide alternative energy sources during ischemia. Al-
though effective for brief periods, no single pharmacologic
therapy or combination of therapies has been demonstrated
to be superior to renal cooling and sustained hypothermia.
Numerous methods for renal cooling and hypothermia
during branch renal artery repair have been described;
however, several steps are common to each branch renal
artery reconstruction. To promote renocortical perfu-
sion, small doses of intravenous mannitol are adminis-
tered.17,27,28 Before the division of the renal artery, intra-
venous heparin (100 U/kg) is administered, and systemic
anticoagulation is verified by activated clotting time. Unless
required for hemostasis, protamine is not routinely admin-
istered for reversal of the heparin effect.
Otherwise, recommended techniques for renal hypo-
thermia range from surface cooling to hypothermic perfu-
sion.10,13,15,20,22,23 In the latter instance, renal protection
has been observed with single, cold bolus perfusion of the
renal artery, intermittent renal artery perfusion, continuous
pulsatile perfusion, renal vein perfusion, and cold perfusionof the collecting system.10 Of these options, our group has
used intermittent, cold perfusion of the renal artery com-
bined with surface cooling. This technique provides for
uniform renal hypothermia and protection well in excess of
that required for branch renal artery repair. Although pul-
satile perfusion may offer superior hypothermic protection
when ischemic times are 12 to 24 hours, this issue is not
relevant to renal artery repair.
Hypothermia appears to be more important than the
composition of perfusate; however, perfusate with an intra-
cellular composition limits ion exchange and intracellular
volume shifts that contribute to organelle dysfunction as-
sociated with decreased activity of membrane-bound
Na-K adenosine triphosphatase.10,29,30 The effective-
ness of this protection strategy is supported by the renal
function estimates observed early after repair: of patients
with patent repair, only two demonstrated 20% increase
in perioperative SCr concentrations.
The operative management described in this consecu-
tive case series differs from previous reports. Other reports
have advocated pelvic autotransplantation after ex vivo
renal artery repair with or without ureteral division and
ureteroneocystostomy.31-33 When applied to renal trans-
plantation, pelvic placement of the kidney allows retroper-
itoneal arterial, venous, and bladder exposure with a mini-
mum of operative dissection. Rejection in the transplanted
kidney is more easily assessed by physical examination and
DUS imaging and more easily biopsied when necessary.
Finally, transplant nephrectomy is facilitated by pelvic
placement of the kidney. In contrast, these advantages of
pelvic autotransplantation do not apply to the patient
group requiring autogenous branch renal artery repair.34
Our group of patients averaged 44 years of age, with
95% survival at 10 years of follow-up. Consequently, this
patient group requires a durable repair capable of renal
function for decades. Renal reconstruction at the iliac level
places the repair at or below sites susceptible to subsequent
atherosclerosis. Moreover, pelvic autotransplantation po-
tentially complicates subsequent management of such vas-
cular disease. Because of these concerns, each of our recon-
structions was made in orthotopic fashion. The ureter is
mobilized but remains intact, eliminating the need for
bladder exposure and ureteral anastomosis.
Before 1992, ex vivo renal artery repairs were routinely
studied with angiography before hospital discharge. In the
absence of validated methods of intraoperative assessment,
an angiogram obtained 5 to 7 days after ex vivo repair
allowed identification of technical defects that threatened
the patency of repair. Early postoperative correction of
technical defects avoided possible renal artery occlusion
and allowed repair in the absence of established postoper-
ative cicatrix. Although invasive and not entirely without
risk, the inadequacy of clinical response to predict patency
was demonstrated by the four ex vivo repairs that occluded
silently in the postoperative period. In each case, hyperten-
sion was considered cured or improved despite complete
failure of repair.
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been evaluated with intraoperative DUS imaging. Major B-
scan defects defined by intraoperative study have been re-
paired immediately. Our enthusiasm for DUS imaging is
supported by the long-term estimates of patency associated
with its use; however, assessment of branch renal artery repairs
after cold ischemia presents special demands.35-38 Imaging
each segmental renal artery branch is technically challenging.
As the Doppler sample volume moves from the main renal
graft into segmental branches, there is often a uniform in-
crease in peak systolic velocity exceeding criteria for stenosis
(ie,1.8 m/s). This finding is especially common when cold
ischemia is 90 minutes. It is distinguished from a major
defect requiring repair by the lack of focal increase and lack of
turbulence. Moreover, the Doppler spectral analysis from the
renal artery early after revascularization may demonstrate a
paucity of diastolic flow consistent with an intrarenal catastro-
phe. Administration of 30 mg of intra-arterial papaverine in
the renal artery graft will resolve this vasoactivity and restore a
normal diastolic Doppler spectrum.
Patient selection for cold perfusion preservation deserves
special comment. The need for hypothermic renal protection
cannot always be accurately predicted preoperatively, espe-
cially when renal protection is dictated by renal vein anatomy
that obscures arterial exposure. Certain arterial pathologies
predictably require branch exposure and frequent branch re-
pair, however, including hilar renal artery aneurysms, failed
PTRA, and renal artery dissections. In these instances, preop-
erative preparations for cold perfusion are made, but the
decision regarding hypothermic protection is made at the
operating table. If hypothermia is selected and adequate ex-
posure is provided, an in situ repair is made with the renal vein
intact. When exposure is compromised, an ex vivo repair is
made after the renal vein is divided. By using this selective
approach, half of branch renal artery repairs in the past year
required cold perfusion protection, and one used cold perfu-
sion leaving the renal vein intact.
Our study has several limitations that deserve com-
ment. The study is a retrospective review of a single insti-
tution’s experience during a 19-year period, with signifi-
cant patient selection bias. With the exception of large
RAA, the presence of severe hypertension was considered a
prerequisite for repair. In addition, the patient group re-
flects a population often referred from a considerable dis-
tance from our center. Given the travel distance, 50% of our
patients have 12 months of anatomic follow-up data for
analysis. Moreover, our results cannot be generalized to the
elderly atherosclerotic patient. Our patient population was
young and predominately female. The renal lesions most
frequently treated were FMD and hilar RAA. Few patients
in this study had atherosclerotic disease.
Nevertheless, the study serves to describe a technique
of managing complex operative renal artery lesions, which
results in a beneficial blood pressure and renal function
response as well as renal salvage. It seems reasonable to
expect that an increasing proportion of open operative
renal artery repairs will require preservation techniques asendovascular therapy is more frequently used for renovas-
cular disease involving the main renal artery.
CONCLUSION
Cold perfusion techniques are useful adjuncts during
repair of complex renal artery pathology. Cold perfusion
provides early renal protection during extended periods of
renal ischemia. Combined with intraoperative completion
duplex, long-term patency of repair and preservation of
renal function favors these strategies of reconstruction.
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Dr G. Patrick Clagett (Dallas, Tex). This is one of the larger
series of ex-vivo or partially ex-vivo renal artery reconstruction and
the results reflect the excellence that one has come to expect from
Dr Hansen’s group. My experience pales in comparison, so I have
little with which to disagree. However, I have three questions:
One, could you provide more detail regarding the precise
nature of the technical problems that led to the need for immediate
revision or postoperative occlusion? The overall incidence of this
problem was approximately 20% in your series, and it would be
helpful to know further details in order to prevent this complica-
tion. What led to the occlusions? Small vein graft kinks? Intimal
flaps? Anastomotic narrowing?
Two, along these lines, do you think the technique of syndac-
tylizing multiple renal artery branches is sometimes problematic? I
have found that this technique can lead to kinking of one or the
other branches and does not always anastomose comfortably to a
vein graft. Because of this, I have preferred either bypassing to
individual branches with branched vein grafts or reimplantation of
accessory branches into either the main renal artery, a vein graft or
even a vein patch after excision of most of the aneurysm wall.
Three, how important is the potassium-rich renal preservation
solution? I agree that the temperature of the renal preservation solu-
tion is probably more important than the composition, and I am
concerned about the possibility of causing inadvertent hyperkalemia
at the completion of the reconstruction. Has this been a problem? I
appreciate the opportunity to discuss this paper and commend the
authors on an excellent presentation and a fine paper.
Dr Teresa Crutchley:With respect to your first question, we
did identify early technical problems in 18.2%, or 12, of ourduplex, which we have performed routinely since 1992. Half of the
technical problems discovered using intraoperative duplex were
defects at the proximal anastomosis or at the aortic clamp sites, and
the other half were due to stenoses at the branch level of repair.
The remaining five patients were occlusions identified on postop-
erative angiography. One of these patients was the previously
discussed solitary kidney who was anuric postoperatively and was
revised immediately for kidney salvage. The remaining four of our
occlusions were clinically inapparent until the angiogram obtained
a week out from surgery, and were therefore not candidates for
intervention.
Regarding your second question about syndactylization, it is
our practice to combine segmental branches whenever possible
into one or two patches that can be anastomosed to the bypass
graft; however, if there is a branch that appears to twist or kink
when combined, it will be anastomosed separately.
Finally, with respect to our use of an intracellular-type perfus-
ate, which is potassium-rich, while we agree that hypothermia is
the more important adjunctive therapy, we also feel that it is
important to use an intracellular composition because it limits the
ion exchange and volume shifts that occur when the sodium-
potassium ATPase pump is inactivated during periods of hypother-
mia. This contributes to less cellular edema. We have not encoun-
tered problems with hyperkalemia, most importantly because in
mobilizing the entire kidney, the collateral blood supply is dis-
rupted. In addition, the renal artery and vein are controlled, as is
the ureter. The amount of potassium that enters a patient’s circu-
lation upon release of the clamps is approximately 10 mEq, which
corresponds to the amount of perfusate left in the kidney upon
re-establishing perfusion.
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Product-limit estimates of follow-up patency of renal artery cold perfusion procedures occlusion or stenosis failure
Occlusion or stenosis
failure time Patent Failure Survival standard error No. failed No. left
0.000 1.0000 0 0 0 68
0.000 0.9853 0.0147 0.0146 1 67
0.000* — — — 1 66
0.100* — — — 1 65
0.100* — — — 1 64
0.200 — — — 2 63
0.200 0.9545 0.0455 0.0257 3 62
0.200* — — — 3 61
0.200* — — — 3 60
0.200* — — — 3 59
0.200* — — — 3 58
0.200* — — — 3 57
0.200* — — — 3 56
0.200* — — — 3 55
0.300 — — — 4 54
0.300 0.9198 0.0802 0.0345 5 53
0.300* — — — 5 52
0.300* — — — 5 51
2.300* — — — 5 50
2.400* — — — 5 49
2.800* — — — 5 48
3.000* — — — 5 47
3.200* — — — 5 46
3.300 0.8998 0.1002 0.0391 6 45
3.400* — — — 6 44
3.900* — — — 6 43
4.100* — — — 6 42
4.100* — — — 6 41
5.800* — — — 6 40
6.100* — — — 6 39
6.900* — — — 6 38
7.600 0.8761 0.1239 0.0447 7 37
8.900* — — — 7 36
12.000 0.8518 0.1482 0.0496 8 35
13.300* — — — 8 34
13.400* — — — 8 33
13.700* — — — 8 32
15.500* — — — 8 31
16.500* — — — 8 30
19.900* — — — 8 29
22.600* — — — 8 28
24.700* — — — 8 27
25.600* — — — 8 26
26.400* — — — 8 25
26.800* — — — 8 24
27.200* — — — 8 23
32.800* — — — 8 22
32.800* — — — 8 21
33.500* — — — 8 20
33.600 0.8092 0.1908 0.0628 9 19
34.400* — — — 9 18
38.500* — — — 9 17
40.100* — — — 9 16
41.900 0.7586 0.2414 0.0766 10 15
49.900 0.7080 0.2920 0.0866 11 14
54.200* — — — 11 13
56.900* — — — 11 12
63.000* — — — 11 11
69.100* — — — 11 10
73.700* — — — 11 9
79.600* — — — 11 8
96.500* — — — 11 7
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Occlusion or stenosis
failure time Patent Failure Survival standard error No. failed No. left
99.800* — — — 11 6
105.500* — — — 11 5
109.200* — — — 11 4
116.000* — — — 11 3
126.900* — — — 11 2
160.000* — — — 11 1
198.800* — — — 11 0
*These times are censored.
